Predicted antiviral activity of tenofovir versus abacavir in combination with a cytosine analogue and the integrase inhibitor dolutegravir in HIV-1-infected South African patients initiating or failing first-line ART

Derache, A; Iwuji, CC; Danaviah, S; Giandhari, J; Marcelin, A-G; Calvez, V; de Oliveira, T; ... Gupta, RK; + view all Derache, A; Iwuji, CC; Danaviah, S; Giandhari, J; Marcelin, A-G; Calvez, V; de Oliveira, T; Dabis, F; Pillay, D; Gupta, RK; - view fewer (2018) Predicted antiviral activity of tenofovir versus abacavir in combination with a cytosine analogue and the integrase inhibitor dolutegravir in HIV-1-infected South African patients initiating or failing first-line ART. Journal of Antimicrobial Chemotherapy 10.1093/jac/dky428 . Green open access

https://ift.tt/2FiRUjP